A prospective multi-center investigational study of IMMray
Enrolling By Invitation
18 years - 99 years
All
Phase
N/A
1 Location
Brief description of study
Brief Summary:
PanFAM-1 is a clinical study for early detection of pancreatic cancer in high-risk groups. The goals of the study are to assess the performance and diagnostic accuracy of the IMMray™ PanCan-d test compared to standard-of-care imaging.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: pancreas
-
Age: 18 years - 99 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 831292
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
